Predictive Potentials of ZEB1-AS1 in Colorectal Cancer Prognosis and Their Correlation with Immunotherapy

Figure 6

Relationship among the risk score, immune infiltration, immunotherapy response to CRC patients, and tumor immune dysfunction exclusion (TIDE). (a) The scores of 16 immune cells. (b) The scores of 13 immune-related functions. (c) The response to immunotherapy. (d) The value of TIDE (^∗ < 0.05; ^∗∗ < 0.01; ^∗∗∗ < 0.001; ns: not significant).

(a)

(b)

(c)

(d)